Related content

γ-Secretase-Regulated Signaling: Notch, APP, and Alzheimer's Disease

By  

Current Psychopharmacology, Vol. 1, Iss. 2, 2012-05 ,pp. : 155-166

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

By D'Onofrio Grazia   Panza Francesco   Frisardi Vincenza   Solfrizzi Vincenzo   Imbimbo Bruno P   Paroni Giulia   Cascavilla Leandro   Seripa Davide   Pilotto Alberto  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 19-37

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer's Disease: Prospects, Limitations and Strategies

By Evin Geneviève   Marijke Fleur Sernee   Masters Colin L.  

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 351-372

Adis International

Access to resources Recommend Favorite

γ-Secretase Inhibitors for Alzheimer's Disease: Balancing Efficacy and Toxicity

By Barten Donna M.   Meredith Jere E.   Zaczek Robert   Houston John G.   Albright Charles F.  

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 87-97

Adis International

Access to resources Recommend Favorite

&ggr;-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1555-1570

Bentham Science Publishers

Access to resources Recommend Favorite